Lusine Kostanyan, MD

GSK, Wavre, Belgium
Wavre, Brabant Wallon, Belgium

I do not have any relevant financial / non-financial relationships with any proprietary interests.

Presentation(s):

• LB745 - Respiratory Syncytial Virus (RSV) Prefusion F Protein Candidate Vaccine (RSVPreF3 OA) is Efficacious in Adults ≥ 60 Years of Age (YOA)

  Thursday, October 20, 2022
  1:45 PM – 1:57 PM US ET